These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36739927)

  • 1. A comprehensive perspective on the disposition, metabolism, and pharmacokinetics of representative multi-components of Dengzhan Shengmai in rats with chronic cerebral hypoperfusion after oral administration.
    Ma C; Sheng N; Li Y; Zheng H; Wang Z; Zhang J
    J Ethnopharmacol; 2023 May; 307():116212. PubMed ID: 36739927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic understanding of the effect of Dengzhan Shengmai capsule on the pharmacokinetics of clopidogrel in rats.
    Chen X; Zhao Z; Chen Y; Gou X; Zhou Z; Zhong G; Cai Y; Huang M; Jin J
    J Ethnopharmacol; 2016 Nov; 192():362-369. PubMed ID: 27459888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4,5 caffeoylquinic acid and scutellarin, identified by integrated metabolomics and proteomics approach as the active ingredients of Dengzhan Shengmai, act against chronic cerebral hypoperfusion by regulating glutamatergic and GABAergic synapses.
    Sheng N; Zheng H; Li M; Li M; Wang Z; Peng Y; Yu H; Zhang J
    Pharmacol Res; 2020 Feb; 152():104636. PubMed ID: 31926275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics, tissue distribution and excretion of saponins after intravenous administration of ShenMai Injection in rats.
    Li Y; Wang H; Wang R; Lu X; Wang Y; Duan M; Li H; Fan X; Wang S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Oct; 1128():121777. PubMed ID: 31487566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the efficacy of Dengzhan Shengmai capsule against heart failure with preserved ejection fraction.
    Kang Z; Wu Y; Ding Y; Zhang Y; Cai X; Yang H; Wei J
    J Ethnopharmacol; 2024 Oct; 333():118419. PubMed ID: 38838924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical profiling of Shengmai injection, tissue distribution and pharmacokinetic characteristics of ginsenosides after intravenous dosing Shengmai injection in rats with cerebral ischemia.
    Wang H; Tang L; Hu S; Kong X; Ouyang Y; Zhang D; Zhang Y; Tang S; Wu H; Yang H
    J Ethnopharmacol; 2024 Jan; 319(Pt 1):117119. PubMed ID: 37659763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic comparisons of schizandrin after oral administration of schizandrin monomer, Fructus Schisandrae aqueous extract and Sheng-Mai-San to rats.
    Xu M; Wang G; Xie H; Huang Q; Wang W; Jia Y
    J Ethnopharmacol; 2008 Feb; 115(3):483-8. PubMed ID: 18060709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An integrated strategy using LC-MS/MS combined with
    Fu J; Zhang H; Liu S; Wu J; Zhang Y; Gao Y; Song F; Qin Y; Hu X; Liu Z
    Food Funct; 2021 Oct; 12(19):8932-8945. PubMed ID: 34606559
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction of the main active components in Shengmai formula mediated by organic anion transporter 1 (OAT1).
    Hou J; Zhong L; Liu J; Liu F; Xia C
    J Ethnopharmacol; 2022 Oct; 296():115515. PubMed ID: 35777609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender-dependent pharmacokinetics of lignans in rats after single and multiple oral administration of Schisandra chinensis extract.
    Xu H; Gan J; Liu X; Wu R; Jin Y; Li M; Yuan B
    J Ethnopharmacol; 2013 May; 147(1):224-31. PubMed ID: 23501155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Research advance in chemical compounds,pharmacological action and clinical application of Dengzhan Shengmai Capsules].
    Mu XM; Mi N; Zu XP; Ye J; Yang PM; Zhang WD
    Zhongguo Zhong Yao Za Zhi; 2019 Sep; 44(18):3917-3923. PubMed ID: 31872725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of bioactive components and multi-component pharmacokinetics of saponins from the leaves of Panax notoginseng in rat plasma after oral administration by LC-MS/MS.
    Ju Z; Li J; Han H; Yang L; Wang Z
    J Sep Sci; 2018 Apr; 41(7):1512-1523. PubMed ID: 29280337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolites profile of Gualou Xiebai Baijiu decoction (a classical traditional Chinese medicine prescription) in rats by ultra-performance liquid chromatography coupled with quadrupole time-of-flight tandem mass spectrometry.
    Lin P; Qin Z; Yao Z; Wang L; Zhang W; Yu Y; Dai Y; Zhou H; Yao X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 May; 1085():72-88. PubMed ID: 29635208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-polysaccharide/herb interactions and compatibility rationality of Sijunzi decoction based on comprehensive pharmacokinetic screening for multi-components in rats with spleen deficiency syndrome.
    Dong B; Ma P; Chen X; Peng Y; Peng C; Li X
    J Ethnopharmacol; 2023 Feb; 302(Pt A):115871. PubMed ID: 36309112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a UFLC-MS/MS method for simultaneous determination of six lignans of Schisandra chinensis (Turcz.) Baill. in rat plasma and its application to a comparative pharmacokinetic study in normal and insomnic rats.
    Wei B; Li Q; Su D; Fan R; Zhao L; Geng L; He B; Chen X; Jia Y; Bi K
    J Pharm Biomed Anal; 2013 Apr; 77():120-7. PubMed ID: 23416367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UFLC-MS/MS method for simultaneous determination of six lignans of Schisandra chinensis (Turcz.) Baill. in normal and insomniac rats brain microdialysates and homogenate samples: towards an in-depth study for its sedative-hypnotic activity.
    Wei B; Li Q; Fan R; Su D; Ou X; Chen K; Chen X; Jia Y; Bi K
    J Mass Spectrom; 2013 Apr; 48(4):448-58. PubMed ID: 23584938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics study of 16 representative components from Baoyuan Decoction in rat plasma by LC-MS/MS with a large-volume direct injection method.
    Lu YY; Chen JF; Song JY; Du ZY; Wang JL; Qian Y; Jiang Y; Guo XY; Tu PF
    Phytomedicine; 2019 Apr; 57():148-157. PubMed ID: 30668317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiota-derived short-chain fatty acids mediate the effects of dengzhan shengmai in ameliorating cerebral ischemia via the gut-brain axis.
    Guo HH; Shen HR; Tang MZ; Sheng N; Ding X; Lin Y; Zhang JL; Jiang JD; Gao TL; Wang LL; Han YX
    J Ethnopharmacol; 2023 Apr; 306():116158. PubMed ID: 36638854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic compatibility of ginsenosides and Schisandra Lignans in Shengmai-san: from the perspective of p-glycoprotein.
    Liang Y; Zhou Y; Zhang J; Rao T; Zhou L; Xing R; Wang Q; Fu H; Hao K; Xie L; Wang G
    PLoS One; 2014; 9(6):e98717. PubMed ID: 24922060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-omics and network pharmacology study reveals the effects of Dengzhan Shengmai capsule against neuroinflammatory injury and thrombosis induced by ischemic stroke.
    Ye J; Huang F; Zeng H; Xu X; Wu G; Tian S; Zhao J; Zhang W
    J Ethnopharmacol; 2023 Apr; 305():116092. PubMed ID: 36587875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.